Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

PURPOSE: Adjuvant therapy for intermediate-risk and high-risk localized prostate cancer decreases the number of deaths from this disease. Surrogates for overall survival (OS) could expedite the evaluation of new adjuvant therapies. METHODS: By June 2013, 102 completed or ongoing randomized trials we...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Oncol
Главные авторы: Xie, Wanling, Regan, Meredith M., Buyse, Marc, Halabi, Susan, Kantoff, Philip W., Sartor, Oliver, Soule, Howard, Clarke, Noel W., Collette, Laurence, Dignam, James J., Fizazi, Karim, Paruleker, Wendy R., Sandler, Howard M., Sydes, Matthew R., Tombal, Bertrand, Williams, Scott G., Sweeney, Christopher J.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2017
Предметы:
ORIGINAL REPORTS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652387/
https://ncbi.nlm.nih.gov/pubmed/28796587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.73.9987
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы